Creating a COVID-19 Response Group working within the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), the European Medicines Agency (EMA) has strengthened the mandate amid the current pandemic. EMA stressed that the new mandate is necessary to address “unprecedented challenges for the epidemiological and regulatory communities. “This role would give ENCePP centres high visibility and recognition as key players in the fight against COVID-19 and for public health protection.” For more information please click here.
Jun
04
Comments are closed.